Double-blind comparison of single doses of DS103-282, baclofen and placebo for suppression of spasticity.
Twelve spastic patients received single oral doses of a new anti-spastic drug DS103-282 (Sandoz) 6 mg, baclofen 20 mg, and placebo on three separate days. Passive stretch responses were measured before administration and for four hours afterwards. DS103-282 was more effective than baclofen, and both...
Na minha lista:
| Publicado no: | J Neurol Neurosurg Psychiatry |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
1980
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC490787/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7217960/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.43.12.1132 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|